Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 1,351-1,375 of 3,186
CompletedNCT04235686

8 Week Multi-site Study of MYDAYIS® for Depression in bipolarity

This study exists to see whether the medication MYDAYIS can play a useful role in care. Researchers are trying to understand how people respond to the medication MYDAYIS in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
CompletedNCT03481049

Individualizing Incentives for Alcohol in the Severely Mentally Ill

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington State University
Condition
Depression
SuspendedNCT04031469

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

BipolarityOtherOver 12 Years
Countries
United States
Sponsor
ProgenaBiome
Condition
Bipolarity
CompletedNCT00457197

Quetiapine for Bipolarity and Alcohol Dependence

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can work better when mental health difficulties overlap with substance use.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
CompletedNCT05328297

A Study of JNJ-55308942 in the Treatment of Depression in bipolarity

This study exists to compare options and see whether the medication JNJ-55308942 offers something meaningfully different. Researchers are trying to understand what the medication JNJ-55308942 could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 64 Years
Countries
Canada, Poland, Spain, United States
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Bipolarity
CompletedNCT00463580

A Study of Infliximab for Treatment Resistant Major Depression

This study exists to see whether the medication Infliximab can play a useful role in care. Researchers are trying to understand whether the medication Infliximab can better support energy, concentration, and everyday functioning.

DepressionOtherFrom 25 Years to 60 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
CompletedNCT02360267

Pediatric Bipolar Registry

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

BipolarityOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity
CompletedNCT04059952

Mechanism of Action of Electroconvulsive Therapy

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
CompletedNCT04870710

Feasibility Electrical Stimulation Study for Visual Hallucinations

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
SuspendedNCT02719392

A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Depression in bipolarity

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
SuspendedNCT04640636

IM Ketamine vs Midazolam for Suicidal ER Patients

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression
WithdrawnNCT06328140

Sleep Quality, Cognitive Performance, and Computerized Cognitive Training

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
George West Mental Health Foundation d/b/a Skyland Trail
Condition
Depression
CompletedNCT05300919

Bipolarity Measures in Clinical Care

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity
CompletedNCT03943537

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia
CompletedNCT01172652

Ziprasidone in Bipolarity With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Palo Alto Health Care System
Condition
Bipolarity
CompletedNCT04285515

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Depression in bipolarity or Major Depressive Disorder

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Russian Federation, Serbia, Ukraine, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
CompletedNCT00178932

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
CompletedNCT06024239

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolarity (BPD)

This study exists to better understand the safety of the medication ABBV-932 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication ABBV-932 in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity
CompletedNCT04004416

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 16 Years to 60 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT05228457

Intensive TMS for Depression in bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Bipolarity
CompletedNCT03158805

Saxenda® in Obese or Overweight Patients With Stable Bipolarity (Investigator Initiated)

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity
CompletedNCT03774641

A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women

This study exists to see whether the medication Prophylactic can make care clearer and more responsive. Researchers are trying to understand whether the medication Prophylactic can better prevent setbacks and support longer-term stability.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
United States | Clinical Trials | HopeStage Research